GTR 73369390
Bids Are Invited For Acquisition Of Srp Medicines
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
73369390
Tendering Authority
Subscribe to view
Tender No
949/2023
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Srp Medicines
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
15-12-2023
Closed
Work Detail
(L1) 6501.218-Acetylcysteine, 600 Mg, Granules, Envelope, 5 G, Route Of Administration: Oral, Units. Size: Unit, (L2) 6501.310-Carvedilol, 3, 125 Mg, Tablet, Blister, (L3) 6501.748-Enalapril, Maleate, 20 Mg, (L4) 6501.2248-Hydralazine, Hydrochloride, 25 Mg, Dragee, (L5) 6501.4756-Aluminum Hydroxide, 60 To 62 Mg/Ml, Oral Suspension, Bottle, 100 To 150 Ml, (L6) 6501.898-Lactulose, 667 Mg/Ml, Syrup, 120 Ml, Dosing Cup, (L7) 6501.1779-Neomycin, Sulfate + Bacitracin, 5 Mg + 250 Iu/G, Dermatological Ointment, Tube, 10 To 15 G, Route Of Administration: Topical, (L8) 6501.1388-Paracetamol, 750 Mg, (L9) 6501.257-Retinol, Acetate (Vitamin A) + Amino Acids + Methionine + Chloramphenicol, 10,000 Iu + 25 Mg + 5 Mg + 5 Mg /G, Ointment, Route Of Administration: Ophthalmic, (L10) 6501.962-Simvastatin, Coated Tablet, (L11) 6501.965-Silver Sulfadiazine, 10 Mg /G (1%), Cream, 50G, (L12) 6501.19643-Sulfamethoxazole + Trimethoprim, 800Mg + 160Mg, (L13) 6501.3181-Desmopressin, Acetate, 0.1 Mg/Ml, Solution, Spray Bottle, 2.5 Ml, Route Of Administration: Nasal
Key Value
Tender Value
1,765,453 - BRL
Tender Documents
Global Tender Document
762a3dfb-2e0e-49d1-837a-daa864af8a19.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.